Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome

Clémence Pontoizeau (1) , Antoine Girard (1) , Habiba Mesbah (1) , Laure-Anne Haumont (1) , Anne Devillers (2) , Adrian Tempescul (3) , Pierre-Yves Salaun (4) , Thierry Lamy (3, 5) , Florence Le Jeune (6, 1) , Xavier Palard-Novello (7)

1 CRLCC - CRLCC Eugène Marquis
2 Département de médecine nucléaire [Rennes]
3 Centre Hospitalier Universitaire [Rennes]
4 CHU - BREST - Med Nucléaire - CHRU Brest - Service de médecine nucléaire
5 MICMAC - Microenvironment, Cell Differentiation, Immunology and Cancer
6 Comportement et noyaux gris centraux = Behavior and Basal Ganglia [Rennes]
7 LTSI - Laboratoire Traitement du Signal et de l'Image

Domains: Life Sciences [q-bio]; Human health and pathology; Psychiatrics and mental health

Clémence Pontoizeau, Antoine Girard, Habiba Mesbah, Laure-Anne Haumont, Anne Devillers, et al.. Prognostic Value of Baseline Total Metabolic Tumor Volume Measured on FDG PET in Patients With Richter Syndrome. Clinical Nuclear Medicine, 2020, 45 (2), pp.118-122. ⟨10.1097/RLU.0000000000002879⟩. ⟨hal-02443930⟩